(Q24234415)

1

0 references

Heidrun Losert

3

0 references

Gunnar Gamper

4

0 references

Marcus Müllner

5

0 references

Harald Herkner

Cochrane Database of Systematic Reviews

6

0 references

publication date

11 May 2011

0 references

published in

0 references

cites work

Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Terlipressin versus norepinephrine to correct refractory arterial hypotension after general anesthesia in patients chronically treated with renin-angiotensin system inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Vasopressin in pediatric vasodilatory shock: a multicenter randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Comparison of Dopamine and Norepinephrine in the Treatment of Shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Cutaneous vascular reactivity and flow motion response to vasopressin in advanced vasodilatory shock and severe postoperative multiple organ dysfunction syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

A comparison of epinephrine and norepinephrine in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Efficacy and safety of dopamine versus norepinephrine in the management of septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Vasopressin versus norepinephrine infusion in patients with septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Impact on blood pressure and intestinal perfusion of dobutamine or dopamine in hypotensive preterm infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Beneficial effects of short-term vasopressin infusion during severe septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Response to dobutamine and dopamine in the hypotensive very preterm infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Early use of vasopressors after injury: caution before constriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Vasopressor and inotropic support in septic shock: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Utility of the shock index in predicting mortality in traumatically injured patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Vasoactive drugs for vasodilatory shock in ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Survey of the use of catecholamines by French physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Vasopressor use in septic shock: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Effect of norepinephrine on the outcome of septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Early goal-directed therapy in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Arcsine test for publication bias in meta-analyses with binary outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Dopamine versus dobutamine for hypotensive preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Epidemiology of sepsis in Victoria, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

21 January 2018

Vasopressors for shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

Systemic Inflammatory Response and Progression to Severe Sepsis in Critically Ill Infected Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

[Vasopressin for therapy of persistent traumatic hemorrhagic shock: The VITRIS.at study]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

7 January 2021

Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

7 January 2021

Comparison of systemic and regional effects of dobutamine and dopexamine in norepinephrine-treated septic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

7 January 2021

Sepsis terminology in pediatrics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

7 January 2021

Comparison of systemic and renal effects of dopexamine and dopamine in norepinephrine-treated septic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

7 January 2021

Regional blood flow and oxygen transport in septic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

7 January 2021

Epinephrine-induced lactic acidosis following cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

7 January 2021

Low-dose vasopressin in the treatment of vasodilatory septic shock

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

7 January 2021

Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

7 January 2021

Dopamine and dobutamine in septic shock a comparison

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003709.PUB3

7 January 2021

10.1002/14651858.CD003709.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

21563137

1 reference

Consolidated OpenCitations Corpus – April 2017